Papers/PMID:22071840
Lycopene for the prevention of prostate cancer.
The Cochrane database of systematic reviews2011The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
lycopene — no detected effect on serum prostate-specific antigen
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Meta-analysis indicated no statistical difference in PSA levels between men randomised to receive lycopene and the comparison group (MD (mean difference) -0.34, 95% CI (confidence interval) -2.01, 1.32).”
Quoted verbatim from Lycopene for the prevention of prostate cancer.. - Study
- meta-analysis
- Population
- Men in a meta-analysis of randomised trials of lycopene for prostate cancer prevention; three RCTs with 154 participants overall, differing in design, participants and lycopene allocation
Effect -0.34 mean difference, 95% CI -2.01 to 1.32
Lycopene for the prevention of prostate cancer.2011PMID:22071840Permalink